FACTORS DETERMINING THE CLINICAL SIGNIFICANCE OF DEPIPTIDYL PEPTIDASE 4 INHIBITORS IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. (2022). World Bulletin of Public Health, 8, 67-72. https://www.scholarexpress.net/index.php/wbph/article/view/651